PROVISION Study Reveals FFRangio's Advantages Over Traditional Wire-Based FFR at TCT 2024

The Cardiovascular Research Foundation's annual Transcatheter Cardiovascular Therapeutics (TCT) conference taking place at the Walter E. Washington Convent...

October 28, 2024 | Monday | News
Adona Medical Achieves Milestone with First-in-Human Use of Novel Interatrial Shunt for Heart Failure

Adona Medical, a Shifamed portfolio company that aims to deliver advanced solutions for heart failure, announced the successful first-in-human use of ...

October 28, 2024 | Monday | News
Novartis Unveils Promising 12-Month Data for Fabhalta® in C3 Glomerulopathy at ASN Kidney Week 2024

Novartis presented 12-month data from the Phase III APPEAR-C3G study at American Society of Nephrology (ASN) Kidney Week 2024 showing that patients with C3...

October 28, 2024 | Monday | News
Exact Sciences to Present Innovative CRC Screening Data at ACG Annual Meeting

Exact Sciences Corp. (NASDAQ: EXAS), a leading provider of cancer screening and diagnostic tests, announced the company will present modeling data evaluati...

October 28, 2024 | Monday | News
Regeneron and Sanofi Present Positive Phase 3 Results for Dupixent in Chronic Spontaneous Urticaria

 Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Sanofi will present positive data from the Phase 3 LIBERTY-CUPID Study C evaluating the inves...

October 25, 2024 | Friday | News
Biogen to Present Key Findings at Clinical Trials on Alzheimer’s Disease Conference

Biogen Inc. (Nasdaq: BIIB) announced upcoming data presentations and programming at the Clinical Trials on Alzheimer’s Disease (CTAD) annual con...

October 25, 2024 | Friday | News
AbbVie and Gedeon Richter Forge New Agreement to Explore Treatments for Neuropsychiatric Disorders

 AbbVie (NYSE: ABBV) and Gedeon Richter Plc. ('Richter') announced a new discovery, co-development and license agreement to advance novel targets for ...

October 25, 2024 | Friday | News
GSK Announces Promising Data for Arexvy Vaccine in Younger Adults at Risk for RSV

GSK plc (LSE/NYSE: GSK) announced new preliminary data for Arexvy (respiratory syncytial virus vaccine, recombinant adjuvanted) in adults aged 18-49 at inc...

October 25, 2024 | Friday | News
Positive Phase 3 Results for Dupixent in Chronic Spontaneous Urticaria to be Unveiled at ACAAI 2024

Positive data from the phase 3 LIBERTY-CUPID Study C evaluating the investigational use of Dupixent (dupilumab) in biologic-naive patients with uncontrolle...

October 25, 2024 | Friday | News
PolTREG’s Early Treatment with PTG-007 Could Offer Functional Cure for Children at Risk of Type 1 Diabetes

Treating diabetes patients earlier with PTG-007 could provide functional cure Recruitment will go ahead after European Medicines Agency approval Comp...

October 24, 2024 | Thursday | News
Eli Lilly’s Donanemab Receives MHRA Approval for Alzheimer's Treatment in Great Britain

Eli Lilly and Company (NYSE: LLY) announced that the Medicines and Healthcare products Regulatory Agency (MHRA) has granted marketing authorization fo...

October 24, 2024 | Thursday | News
Interius BioTherapeutics Doses First Patient in Groundbreaking Trial of INT2104, a First-in-Class In Vivo CAR Gene Therapy

INT2104 is a novel in vivo chimeric antigen receptor (CAR) gene therapy designed to generate CAR-T and CAR-NK cells in the patient’s body to target...

October 23, 2024 | Wednesday | News
Sangamo Therapeutics Secures FDA Pathway for Accelerated Approval of Gene Therapy for Fabry Disease

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced the outcome of a recent successful interaction with the U.S.&nbs...

October 23, 2024 | Wednesday | News
Grifols Partners with BARDA to Develop Eye Drops for Sulfur Mustard Ocular Injury

Grifols (MCE:GRF, MCE:GRF.P, NASDAQ:GRFS), a global healthcare company and leading manufacturer of plasma-derived medicines, announced it has established a...

October 23, 2024 | Wednesday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2024 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close